Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor using maltose binding protein fused heparinase I

Biochemical Engineering Journal

Volumn 46, Issue 2, 2009, Pages 193-198

  Ye, Fengchun ^a   Kuang, Ying ^a   Chen, Shuo ^a   Zhang, Chong ^a   Chen, Yin ^a   Xing, Xin Hui ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Affinity; Enzyme; Fusion protein; Heparinase; Low molecular weight heparin; Membrane; Stirred tank

Indexed keywords

AFFINITY; FUSION PROTEIN; HEPARINASE; LOW MOLECULAR WEIGHT HEPARIN; STIRRED-TANK;

BIOREACTORS; ENZYMES; INDUSTRIAL CHEMICALS; MALTOSE; MEMBRANES; MOLECULAR WEIGHT; POLYSACCHARIDES; TANKS (CONTAINERS); ULTRAFILTRATION;

WEIGHING;

BLOOD CLOTTING FACTOR 10A; HEPARIN LYASE; HEPARIN LYASE 1; LOW MOLECULAR WEIGHT HEPARIN; MALTOSE BINDING PROTEIN; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; BIOREACTOR; CHEMICAL REACTION; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG SYNTHESIS; ENZYME MECHANISM; MOLECULAR WEIGHT; PRIORITY JOURNAL; QUALITY CONTROL; TEMPERATURE SENSITIVITY; ULTRAFILTRATION;

EID: 67749130626     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2009.05.007     Document Type: Article

References (20)

1. Hirsh J., and Raschke R. Heparin and low-molecular-weight heparin-The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 188s-203s
2. Hausser H.J., and Brenner R.E. Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro. J. Cell Biochem. 91 (2004) 1062-1073
3. Sundaram M., Qi Y.W., Shriver Z., Liu D.F., Zhao G.L., Venkataraman G., Langer R., and Sasisekharan R. Rational design of low-molecular weight heparins with improved in vivo activity. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 651-656
4. Shi F., Ji S.L., Chi Y.Q., and Zhang T.M. Preparation of LMWH and the relationship between its structure and bioactivity. Chin. J. Biochem. Pharmaceut. 24 (2003) 101-104
5. Linhardt R.J., and Gunay N.S. Production and chemical processing of low molecular weight heparins. Semin. Thromb. Hemost. 25 (1999) 5-16
6. J.I. Nielsen, F. Denmark, Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin, US Patent 5106734 (1992).
7. Hedner U. Development of tinzaparin: a heparinase-digested low-molecular-weight heparin. Semin. Thromb. Hemost. 26 (2000) 23-29
8. Yang V.C., Linhardt R.J., Bernstein H., Cooney C.L., and Langer R. Purification and characterization of heparinase from Flavobacterium heparinum. J. Biol. Chem. 260 (1985) 1849-1857
9. Lohse D.L., and Linhardt R.J. Purification and characterization of heparin lyase from Flavobacterium heparinum. J. Biol. Chem. 276 (1992) 24347-24355
10. Chen Y., Xing X.H., and Lou K. Construction of recombinant Escherichia coli for over-production of soluble heparinase I by fusion to maltose-binding protein. Biochem. Eng. J. 23 (2005) 155-159
11. Chen Y., Xing X.H., Ye F.C., Kuang Y., and Luo M.F. Production of MBP-HepA fusion protein in recombinant Escherichia coli by optimization of culture medium. Biochem. Eng. J. 34 (2007) 114-121
12. Kuang Y., Xing X.H., Chen Y., Ye F.C., Yan Y.Y., Liu Z., and Bi R.C. Production of heparin oligosaccharides by fusion protein of MBP-heparinase I and the enzyme thermostability. J. Mol. Catal. B: Enzym. 43 (2006) 90-95
13. Ahsan A., Jeske W., Mardiguian J., and Fareed J. Feasibility study of heparin mass calibrator as a Gpc calibrator for heparins and low-molecular-weight heparins. J. Pharm. Sci. 83 (1994) 197-201
14. Fan H.H., Liu J.X., and Xu K.S. Measurement of molecular weight and molecular weight distribution of low molecular weight heparin. Chin. Pharmaceut. J. 34 (1999) 332-334
15. European Pharmacopoeia. Heparins, Low-molecular-mass vol. 5.0 (2005), European Pharmacopoeia pp. 1717-1719
16. Shaya D., Tocilj A., Li Y.G., Myette J., Venkataraman G., Sasisekharan R., and Cygler M. Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J. Biol. Chem. 281 (2006) 15525-15535
17. Cohen D.M., and Linhardt R.J. Randomness in the heparin polymer: computer simulations of alternative action patterns of heparin lyase. Biopolymers 30 (1990) 733-741
18. Jandik K.A., Gu K.A., and Linhardt R.J. Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology 4 (1994) 289-296
19. Petitiou M., Barzu T., and Herault J.P. A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation. Glycobiology 7 (1997) 323-327
20. Casu B., and Oreste P. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Biochem. J. 97 (1981) 599-609